
Company valuation, historical trends, and peer comparisons.
According to Knight Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.05B. This represents a change of 49.51% compared to the average of 702.81M of the last 4 quarters.
The mean historical Enterprise Value of Knight Therapeutics Inc. over the last ten years is 670.57M. The current 1.05B Enterprise Value has changed 56.70% with respect to the historical average. Over the past ten years (40 quarters), KHTRF's Enterprise Value was at its highest in in the December 2016 quarter at 1.02B. The Enterprise Value was at its lowest in in the March 2021 quarter at 470.29M.
Average
670.57M
Median
609.29M
Minimum
508.91M
Maximum
952.28M
Discovering the peaks and valleys of Knight Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 54.74%
Maximum Annual Enterprise Value = 952.28M
Minimum Annual Increase = -44.17%
Minimum Annual Enterprise Value = 508.91M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 603.84M | 18.65% |
| 2024 | 508.91M | -10.42% |
| 2023 | 568.08M | -5.50% |
| 2022 | 601.15M | -2.21% |
| 2021 | 614.74M | 15.63% |
| 2020 | 531.64M | -44.17% |
| 2019 | 952.28M | 11.57% |
| 2018 | 853.56M | 23.72% |
| 2017 | 689.91M | -11.73% |
| 2016 | 781.63M | 54.74% |
The current Enterprise Value of Knight Therapeutics Inc. (KHTRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
560.28M
5-year avg
579.34M
10-year avg
670.57M
Knight Therapeutics Inc.’s Enterprise Value is less than Hua Medicine (Shanghai) Ltd. (1.18B), greater than Cresco Labs Inc. (769.15M), greater than Verano Holdings Corp. (765.14M), greater than PureTech Health plc (307.16M), less than Surgical Science Sweden AB (publ) (2.42B), greater than Allergy Therapeutics plc (98.99M), greater than Avacta Group Plc (278.76M), greater than COLTENE Holding AG (323.76M), greater than Vitalhub Corp. (440.96M), greater than BioInvent International AB (publ) (29.69M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.18B | $303.18M | |
| 769.15M | $210.00M | |
| 765.14M | $470.36M | |
| 307.16M | $382.48M | |
| 2.42B | $279.37M | |
| 98.99M | $756.30M | |
| 278.76M | $413.77M | |
| 323.76M | $334.62M | |
| 440.96M | $362.93M | |
| 29.69M | $26.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Knight Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Knight Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Knight Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Knight Therapeutics Inc. (KHTRF)?
What is the 3-year average Enterprise Value for Knight Therapeutics Inc. (KHTRF)?
What is the 5-year average Enterprise Value for Knight Therapeutics Inc. (KHTRF)?
How does the current Enterprise Value for Knight Therapeutics Inc. (KHTRF) compare to its historical average?